Director/PDMR Shareholding

RNS Number : 8358P
GlaxoSmithKline PLC
07 October 2011
 



 

 

 

 

 

 

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the "Plan") notified the Company and the under-mentioned persons on 7 October 2011 of an increase in their notional interests in Ordinary shares and ADRs at a price of 1345 pence per share and $41.83 per share following the re-investment of dividends paid to shareholders on 6 October 2011.

 

 

 

Mr A P Witty

Acquisition of 384 Ordinary shares under the dividend re-investment element of the Plan (personal contribution).



 

 

 

Mr S M Bicknell

 

 

 

 

 

Mrs D P Connelly   

 

 

 

 

 

Mr D S Redfern      

 

 

 

 

 

Dr M M Slaoui

 

 

 

 

 

Ms C Thomas 

 

 

 

 

 

Mr D E Troy     

 

 

 

 

 

Dr P J T Vallance

 

 

 

 

 

 

Acquisition of 384 Ordinary shares under the matching element of the Plan (Company contribution).

 

Acquisition of 81 Ordinary shares under the dividend re-investment element of the Plan (personal contribution).

 

Acquisition of 81 Ordinary shares under the matching element of the Plan (Company contribution).

 

Acquisition of 47 ADRs under the dividend re-investment element of the Plan (personal contribution).

 

Acquisition of 47 ADRs under the matching element of the Plan (Company contribution).

 

Acquisition of 91 Ordinary shares under the dividend re-investment element of the Plan (personal contribution).

 

Acquisition of 91 Ordinary shares under the matching element of the Plan (Company contribution).

 

Acquisition of 236 ADRs under the dividend re-investment element of the Plan (personal contribution).

 

Acquisition of 236 ADRs under the matching element of the Plan (Company contribution).

 

Acquisition of 20 Ordinary shares under the dividend re-investment element of the Plan (personal contribution).

 

Acquisition of 20 Ordinary shares under the matching element of the Plan (Company contribution).

 

Acquisition of 118 ADRs under the dividend re-investment element of the Plan (personal contribution).

 

Acquisition of 118 ADRs under the matching element of the Plan (Company contribution).

 

Acquisition of 181 Ordinary shares under the dividend re-investment element of the Plan (personal contribution).

 

Acquisition of 181 Ordinary shares under the matching element of the Plan (Company contribution).

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

7 October 2011

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDDLFBFBFBFBK

Companies

GSK (GSK)
UK 100

Latest directors dealings